Influenza vaccination and interruption of methotrexate in adult patients in the COVID-19 era: an ongoing dilemma
Lancet Rheumatol
.
2021 Jan;3(1):e9-e10.
doi: 10.1016/S2665-9913(20)30392-1.
Epub 2020 Nov 10.
Authors
Puja Mehta
1
2
,
Emilie Sanchez
3
,
Elena Moraitis
4
,
Nicky Longley
5
,
Dennis W Lendrem
6
7
,
Ian P Giles
8
2
,
Rachel C Chambers
1
,
Coziana Ciurtin
9
,
John D Isaacs
6
7
Affiliations
1
Centre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College London, WC1E 6JF London, UK.
2
Department of Rheumatology, University College London Hospital (UCLH), London, UK.
3
Department of Clinical Virology, University College London Hospital (UCLH), London, UK.
4
Rheumatology Department, Great Ormond Street Hospital for Children, London, UK.
5
Hospital for Tropical Diseases, UCLH and London School of Hygiene & Tropical Medicine, London, UK.
6
Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
7
Musculoskeletal Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
8
Centre for Rheumatology Research, Division of Medicine, University College London, WC1E 6JF London, UK.
9
Centre for Adolescent Rheumatology, Division of Medicine, University College London, WC1E 6JF London, UK.
PMID:
33521669
PMCID:
PMC7833938
DOI:
10.1016/S2665-9913(20)30392-1
No abstract available